Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Coagulation abnormalities, thrombosis, and endothelial dysfunction have been described in
COVID-19 patients. Spontaneous muscle hematoma (SMH) is a rare complication in COVID …

Acquires hemophilia A (AHA) is rare bleeding condition commonly associated with
malignancy, autoimmune disease, or pregnancy. We report a case of a 69‐year‐old …

A variety of autoimmune disorders have been reported after viral illnesses and specific
vaccinations. Cases of de novo immune thrombocytopenia (ITP) have been reported after …

Underlying mechanisms of multi-organ manifestations and exacerbated inflammation in
COVID-19 are yet to be delineated. The hypothesis of SARS-CoV-2 triggering autoimmunity …

Background Acquired haemophilia A (AHA) is a rare bleeding disorder due to
autoantibodies to coagulation factor VIII that may be secondary to autoimmune diseases …

Acquired hemophilia A (AHA) is a rare autoimmune disease caused by neutralizing
autoantibodies against coagulation Factor VIII. Immunomodulatory effects of SARS-CoV-2 …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
strongly associated with immune-mediated reactions, including the development of …

Acquired haemophilia A (AHA) is a rare bleeding disorder caused by inhibitory
autoantibodies against coagulation factor VIII (FVIII). AHA is a disease that most commonly …

Hemostasis reflects a homeostatic mechanism that aims to balance out pro-coagulant and
anti-coagulant forces to maintain blood flow within the circulation. Simplistically, a relative …